Financial statements Albertis Laboratories
Balance sheet of Albertis Laboratories
Company age:
Age:
5 y. 1 m. 10 d.
Share capital:
Share capital:
10 000 PLN
Balance sheet data of ALBERTIS LABORATORIES
|
Year
|
2020
|
2021
|
2022
|
|---|---|---|---|
| Total assets | 163 282,41 | 326 202,23 | 647 676,13 |
| A. Fixed assets | 0,00 | 41 666,67 | 21 666,67 |
| B. Current assets | 163 282,41 | 284 535,56 | 626 009,46 |
| C. Share capital contributions (basic funds) | - | - | - |
| D. Own shares (stocks) | - | - | - |
| Total liabilities | 163 282,41 | 326 202,23 | 647 676,13 |
| A. Equity | 115 894,26 | 130 992,07 | 49 792,34 |
| B. Liabilities and provisions for liabilities | 47 388,15 | 195 210,16 | 597 883,79 |
| I. Long-term liabilities | - | - | - |
| II. Short-term liabilities | - | - | - |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.